These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22996768

  • 1. [Responses to treatment and switching tyrosine kinase inhibitors in gastrointestinal stromal tumor(GIST)].
    Nishida T, Wakasugi M, Ueshima S.
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1330-5. PubMed ID: 22996768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
    Hsu CC, Wu CE, Chen JS, Tseng JH, Chiang KC, Liu YY, Tsai CY, Cheng CT, Chen TW, Jan YY, Yeh TS, Chen YY, Yeh CN.
    Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
    Prior JO, Montemurro M, Orcurto MV, Michielin O, Luthi F, Benhattar J, Guillou L, Elsig V, Stupp R, Delaloye AB, Leyvraz S.
    J Clin Oncol; 2009 Jan 20; 27(3):439-45. PubMed ID: 19064982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
    Reichardt P, Blay JY, Gelderblom H, Schlemmer M, Demetri GD, Bui-Nguyen B, McArthur GA, Yazji S, Hsu Y, Galetic I, Rutkowski P.
    Ann Oncol; 2012 Jul 20; 23(7):1680-7. PubMed ID: 22357255
    [Abstract] [Full Text] [Related]

  • 11. The role of KIT in the management of patients with gastrointestinal stromal tumors.
    Hornick JL, Fletcher CD.
    Hum Pathol; 2007 May 20; 38(5):679-87. PubMed ID: 17437861
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
    Nishida T, Doi T, Naito Y.
    Expert Opin Pharmacother; 2014 Oct 20; 15(14):1979-89. PubMed ID: 24990162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
    Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.
    BMC Cancer; 2012 Mar 22; 12():107. PubMed ID: 22439647
    [Abstract] [Full Text] [Related]

  • 16. [Molecular mechanism and therapeutic strategy for resistance to tyrosine kinase inhibitors in targeted treatment of gastrointestinal stromal tumors].
    Xu J, Cao H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 22; 16(3):288-91. PubMed ID: 23536353
    [Abstract] [Full Text] [Related]

  • 17. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
    Janeway KA, Albritton KH, Van Den Abbeele AD, D'Amato GZ, Pedrazzoli P, Siena S, Picus J, Butrynski JE, Schlemmer M, Heinrich MC, Demetri GD.
    Pediatr Blood Cancer; 2009 Jul 22; 52(7):767-71. PubMed ID: 19326424
    [Abstract] [Full Text] [Related]

  • 18. [Resistance and treatment strategy of gastrointestinal stromal tumor target therapy].
    Lu W, Lu WQ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar 22; 15(3):309-12. PubMed ID: 22454182
    [Abstract] [Full Text] [Related]

  • 19. Novel approaches to imatinib- and sunitinib-resistant GIST.
    Reichardt P.
    Curr Oncol Rep; 2008 Jul 22; 10(4):344-9. PubMed ID: 18778561
    [Abstract] [Full Text] [Related]

  • 20. Hits and misses in targeting pediatric cancers.
    Bernstein ML.
    Pediatr Blood Cancer; 2009 Jul 22; 52(7):751-2. PubMed ID: 19185009
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.